Guangzhou, China
Guangzhou, China

Time filter

Source Type

The cardiac marker testing market in North America is primarily driven by the increasing incidence of cardiovascular diseases, growing public-private investments, NIH support towards the development of novel cardiac biomarkers, and rising geriatric population. The global cardiac marker testing market is estimated to grow at a CAGR of 8.8% from 2016 to 2021 to reach USD 3.50 billion by 2021. Full details on this report “Cardiac Marker Testing Market” spread across 159 Pages, Profiling 11 Companies and Supported with 110 Tables and 33 Figures is now available at http://www.reportsnreports.com/reports/729436-cardiac-marker-testing-market-by-type-troponin-i-t-ck-mb-myoglobin-bnp-hscrp-product-reagent-instrument-method-chemiluminescence-elisa-disease-myocardial-infarction-congestive-heart-failure-test-st-to-2021.html . North America held the largest share of the global cardiac marker testing market, followed by Europe. However, the Asia-Pacific market is expected to register the highest CAGR of 11.7% from 2016 to 2021. Factors such as rising prevalence and incidence of cardiovascular diseases and public-private initiatives to increase awareness about early cardiac disease diagnosis are stimulating the growth of the cardiac marker testing market in the Asia-Pacific region. On the other hand, technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are the key factors limiting the growth of the global cardiac marker testing market. As of 2016, Emerging markets, including India and China, have become attractive destinations for companies engaged in the development and marketing of cardiac biomarkers. Rising prevalence and incidence of cardiovascular diseases is among the major driving factors for the growth of this market in China and India. For instance, annual cardiovascular events in China were projected to increase by more than 50% from 2010 to 2030. Click Now for PDF Sample Download of this Study Report The global cardiac marker testing technology market is segmented on the basis of type of testing into laboratory testing and point-of-care testing. The point-of-care testing segment is the fastest-growing segment in this market owing to the advantages offered by it (such as reductions in length of stay, improved emergency department efficiency, increased patient satisfaction and user experience, better turnaround times, and simpler sample collection method versus that in central lab testing), rising hospital point-of-care (POC) testing procedures, and technological advancements with regard to the development of advanced, faster, and easy-to-use devices. Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.) Alere, Inc. (U.S.), bioMérieux SA (France), LSI Medience Corporation (a subsidiary of Mitsubishi Chemical Holdings Corporation, Japan), Ortho Clinical Diagnostics (a subsidiary of The Carlyle Group, U.S.), Randox laboratories Ltd (U.K.), and Guangzhou Wondfo Biotech Co., Ltd. (Wondfo) (China) are some of the key players operating in the global cardiac marker testing market. Connect for More Details for Discount and More Information “Cardiac Marker Testing Market by Type (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Product (Reagent, Instrument), Method (Chemiluminescence, ELISA), Disease (Myocardial Infarction, Congestive Heart Failure), Testing (Lab, POC) - Global Forecast to 2021” report @ http://www.reportsnreports.com/contacts/discount.aspx?name=729436 . North America is expected to account for the largest share of the global cardiac marker testing market in 2016, followed by Europe and Asia-Pacific. The Asia-Pacific market is expected to register the highest CAGR during the forecast period. The high growth in this segment can be attributed to rising prevalence and incidence of cardiovascular diseases, public–private initiatives to increase awareness related to early cardiac disease diagnosis in patients and physicians, and increasing knowledge about technological advancements among lab professionals and cardiologists due to ongoing conferences and seminars in the region. Explore more reports on Medical Devices at http://www.reportsnreports.com/market-research/medical-devices/ .


The cardiac marker testing market in North America is primarily driven by the increasing incidence of cardiovascular diseases, growing public-private investments, NIH support towards the development of novel cardiac biomarkers, and rising geriatric population. The global cardiac marker testing market is estimated to grow at a CAGR of 8.8% from 2016 to 2021 to reach USD 3.50 billion by 2021. Factors such as growing incidences of cardiovascular diseases, the rapidly increasing geriatric population, growing funding from public–private organizations for research on cardiac biomarkers and ongoing clinical trials for the identification of novel cardiac biomarkers are fueling the growth of the cardiac marker testing market. Geographically, North America commands the largest share of the global cardiac marker testing market in 2016, followed by Europe. Full details on this report “Cardiac Marker Testing Market” spread across 159 Pages, Profiling 11 Companies and Supported with 110 Tables and 33 Figures is now available at http://www.rnrmarketresearch.com/cardiac-marker-testing-market-by-type-troponin-i-t-ck-mb-myoglobin-bnp-hscrp-product-reagent-instrument-method-chemiluminescence-elisa-disease-myocardial-infarction-congestive-heart-failure-test-st-to-2021-market-report.html . On the other hand, technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are the key factors limiting the growth of the global cardiac marker testing market. As of 2016, North America held the largest share of the global cardiac marker testing market, followed by Europe. However, the Asia-Pacific market is expected to register the highest CAGR of 11.7% from 2016 to 2021. Factors such as rising prevalence and incidence of cardiovascular diseases and public-private initiatives to increase awareness about early cardiac disease diagnosis are stimulating the growth of the cardiac marker testing market in the Asia-Pacific region. Emerging markets, including India and China, have become attractive destinations for companies engaged in the development and marketing of cardiac biomarkers. Rising prevalence and incidence of cardiovascular diseases is among the major driving factors for the growth of this market in China and India. For instance, annual cardiovascular events in China were projected to increase by more than 50% from 2010 to 2030. Click Now for PDF Sample Download of this Study Report The global cardiac marker testing technology market is segmented on the basis of type of testing into laboratory testing and point-of-care testing. The point-of-care testing segment is the fastest-growing segment in this market owing to the advantages offered by it (such as reductions in length of stay, improved emergency department efficiency, increased patient satisfaction and user experience, better turnaround times, and simpler sample collection method versus that in central lab testing), rising hospital point-of-care (POC) testing procedures, and technological advancements with regard to the development of advanced, faster, and easy-to-use devices. Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.) Alere, Inc. (U.S.), bioMérieux SA (France), LSI Medience Corporation (a subsidiary of Mitsubishi Chemical Holdings Corporation, Japan), Ortho Clinical Diagnostics (a subsidiary of The Carlyle Group, U.S.), Randox laboratories Ltd (U.K.), and Guangzhou Wondfo Biotech Co., Ltd. (Wondfo) (China) are some of the key players operating in the global cardiac marker testing market. Connect for More Details for Discount and More Information “Cardiac Marker Testing Market by Type (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Product (Reagent, Instrument), Method (Chemiluminescence, ELISA), Disease (Myocardial Infarction, Congestive Heart Failure), Testing (Lab, POC) - Global Forecast to 2021” report @ http://www.rnrmarketresearch.com/contacts/discount?rname=733631 . North America is expected to account for the largest share of the global cardiac marker testing market in 2016, followed by Europe and Asia-Pacific. The Asia-Pacific market is expected to register the highest CAGR during the forecast period. The high growth in this segment can be attributed to rising prevalence and incidence of cardiovascular diseases, public–private initiatives to increase awareness related to early cardiac disease diagnosis in patients and physicians, and increasing knowledge about technological advancements among lab professionals and cardiologists due to ongoing conferences and seminars in the region. Explore more reports on Medical Devices at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices .


Patent
Guangzhou Wondfo Biotech. Co. | Date: 2013-05-01

An analyzing and reading device and an analyzing and reading method, for reading and analyzing a test strip for assay detection are disclosed. The test strip has a detection zone and a blank zone, the device includes a photoelectric detection circuit and a processor, wherein the photoelectric detection circuit includes at least two light sources which locate corresponding to the positions of the detection zone and the blank zone of the test strip and are able to emit lights corresponding to the detection zone and blank zone of the test strip, and at least one optical detectors which receive reflected lights from the above two zones; wherein lights emitted by the at least two light sources irradiate the detection zone and blank zone of the strip and are reflected therefrom, and then are received by the optical detector, which in turn feedback the detection information to the processor; the processor making analysis and decision based on the detection information received. The analyzing and reading device and method according to the present invention have high accuracy and less interference when reading.


Patent
Guangzhou Wondfo Biotech. Co. | Date: 2011-08-26

An analyzing and reading device and an analyzing and reading method, for reading and analyzing a test strip for assay detection are disclosed. The test strip has a detection zone and a blank zone, the device includes a photoelectric detection circuit and a processor, wherein the photoelectric detection circuit includes at least two light sources which locate corresponding to the positions of the detection zone and the blank zone of the test strip and are able to emit lights corresponding to the detection zone and blank zone of the test strip, and at least one optical detectors which receive reflected lights from the above two zones; wherein lights emitted by the at least two light sources irradiate the detection zone and blank zone of the strip and are reflected therefrom, and then are received by the optical detector, which in turn feedback the detection information to the processor; the processor making analysis and decision based on the detection information received. The analyzing and reading device and method according to the present invention have high accuracy and less interference when reading.


Patent
Guangzhou Wondfo Biotech. Co. | Date: 2013-05-22

A device and method for determining the assay result is disclosed. The device includes a photoelectric detection circuit and a processor, and an optical detection device which is set with a detection zone and a blank zone for measuring assay results, and the photoelectric detection circuit detects the light-reflection intensity signal, and feeds back the detected information to the processor, and the processor is preset with a threshold value changing with time, and determined value processed by the processor is compared with the preset threshold value to obtain the result of assay. The method for determining the assay result display the result when confirmed determined value is bigger than the preset threshold value or can not reach preset threshold value within a fixed time or detected signal can not be determined, wherein the threshold value changes with the time. The device and method for determining the assay result work more efficiently, measure more accurately and cost less than the prior art.


Patent
Guangzhou Wondfo Biotech. Co. | Date: 2015-01-20

A device and method for determining the assay result is disclosed. The device includes a photoelectric detection circuit and a processor, and an optical detection device which is set with a detection zone and a blank zone for measuring assay results, and the photoelectric detection circuit detects the light-reflection intensity signal, and feeds back the detected information to the processor, and the processor is preset with a threshold value changing with time, and determined value processed by the processor is compared with the preset threshold value to obtain the result of assay. The method for determining the assay result display the result when confirmed determined value is bigger than the preset threshold value or can not reach preset threshold value within a fixed time or detected signal can not be determined, wherein the threshold value changes with the time. The device and method for determining the assay result work more efficiently, measure more accurately and cost less than the prior art.


A method and system for intelligently identifying and reading an immunochromatographic strip is disclosed. The method includes the following steps: (a) preparing an immunochromatographic strip provided with a bar code, that is, setting a bar code on an immunochromatographic strip to form a bar code layer; (b) identifying the immunochromatographic strip provided with a bar code through a bar code identification circuit, and dispatching an analysis program corresponding to the type of the immunochromatographic strip provided with a bar code; (c) transmitting visible light to irradiate the immunochromatographic strip provided with a bar code through a light-emitting diode (LED) circuit controlled by a central processing unit; receiving reflected or transmitted light through a photoelectrical sensor and converting the received light into electrical signals; and then amplifying the electrical signals through a signal amplification circuit and transmitting the amplified signals to the central processing unit in order to analyze the signals through the analysis program dispatched in step (b); and (d) outputting an analysis result.


Patent
Guangzhou Wondfo Biotech. Co. | Date: 2011-08-26

A device and method for determining the assay result is disclosed. The device includes a photoelectric detection circuit and a processor, and an optical detection device which is set with a detection zone and a blank zone for measuring assay results, and the photoelectric detection circuit detects the light-reflection intensity signal, and feeds back the detected information to the processor, and the processor is preset with a threshold value changing with time, and determined value processed by the processor is compared with the preset threshold value to obtain the result of assay. The method for determining the assay result display the result when confirmed determined value is bigger than the preset threshold value or can not reach preset threshold value within a fixed time or detected signal can not be determined, wherein the threshold value changes with the time. The device and method for determining the assay result work more efficiently, measure more accurately and cost less than the prior art.


Trademark
Guangzhou Wondfo Biotech Co. | Date: 2016-07-18

Pharmaceutical preparations; chemico-pharmaceutical preparations; preparations of microorganisms for medical and veterinary use; biological preparations for medical purposes; chemical preparations for pharmaceutical purposes; chemical preparations for medical purposes; enzyme preparations for medical purposes; chemical preparations for the diagnosis of pregnancy; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes. Nursing appliances; blood testing apparatus; medical apparatus and instruments; testing apparatus for medical purposes; apparatus for use in medical analysis; fumigation apparatus for medical purposes; medical apparatus, namely, spirometers; thermometers for medical purposes; diagnostic apparatus for medical purposes; arterial blood pressure measuring apparatus.


Trademark
Guangzhou Wondfo; Biotech Co. | Date: 2014-02-11

Instrument cases for use by surgeons and doctors; blood testing apparatus; medical apparatus and instruments; apparatus for use in medical analysis; testing apparatus for medical purposes; diagnostic apparatus for medical purposes; X-ray apparatus for medical purposes; lasers for medical purposes; physiotherapy apparatus; dialyzers.

Loading Guangzhou Wondfo Biotech Co. collaborators
Loading Guangzhou Wondfo Biotech Co. collaborators